'On consolidated basis
Quarter ended December 2025 compared with Quarter ended December 2024.
Net sales (including other operating income) of Dr Lal Pathlabs has increased 10.57% to Rs 659.8 crore. Operating profit margin has jumped from 25.81% to 27.17%, leading to 16.43% rise in operating profit to Rs 179.30 crore. Raw material cost as a % of total sales (net of stock adjustments) decreased from 19.61% to 19.51%. Employee cost decreased from 21.18% to 20.38%. Other expenses fell from 33.40% to 32.93%. Selling and administration expenses fell from 14.53% to 14.52%.
Other income fell 2.79% to Rs 24.4 crore. PBIDT rose 13.74% to Rs 203.7 crore. Provision for interest rose 35.85% to Rs 7.2 crore.
PBDT rose 13.06% to Rs 196.5 crore. Provision for depreciation rose 18.59% to Rs 42.1 crore.
Profit before tax grew 11.64% ...
Pleaselogin & subscribe to view the full report.
More Reports
|
|